Revenue Recognition - Drug Discovery (Details) - USD ($)	3 Months Ended
Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Net receivables	$ 27,253,000		$ 83,041,000
Deferred revenue	0		72,000
BMGFT \| Related Party
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Software contribution revenue recognition	0	$ 3,844,000
Net receivables	0		0
Software contribution	72,000	499,000
Agreement with Gates Ventures, LLC
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Software contribution revenue recognition amount	9,000,000
Software contribution revenue recognition	0	0
Deferred income	0		0
Net receivables	0		0
July 2024 Agreement with Bill & Melinda Gates Foundation
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Software contribution revenue recognition	0	3,844,000
Deferred income	0		0
Net receivables	0		$ 0
Drug discovery
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Milestone payment yet to be achieved	0	2,000,000
Revenue recognized with milestones	$ 0	$ 487,000

Milestone payment yet to be achieved.

No definition available.

Name:	sdgr_MilestonePaymentYetToBeAchieved
Namespace Prefix:	sdgr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue recognized for milestone payment.

+ References

No definition available.

+ Details

Name:	sdgr_RevenueRecognizedForMilestonePayment
Namespace Prefix:	sdgr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Software contribution revenue recognition amount.

+ References

No definition available.

+ Details

Name:	sdgr_SoftwareContributionRevenueRecognitionAmount
Namespace Prefix:	sdgr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Software contribution revenue recognized.

+ References

No definition available.

+ Details

Name:	sdgr_SoftwareContributionRevenueRecognized
Namespace Prefix:	sdgr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-2

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section 25
-Paragraph 2
-SubTopic 10
-Topic 470
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481174/470-10-25-2

+ Details

Name:	us-gaap_DeferredIncome
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of revenue that is not accounted for under Topic 606.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RevenueNotFromContractWithCustomer
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=sdgr_BillAndMelindaGatesFoundationTrustMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sdgr_AgreementWithGatesVenturesLimitedLiabilityCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sdgr_July2024AgreementWithBillMelindaGatesFoundationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=sdgr_DrugDiscoveryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: